Cong Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cong Tan has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Shujuan Ni
Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China
12 shared publications - Xiang Du
Institutes of Biomedical Sciences, Fudan University, Shanghai, China
10 shared publications Qinghua Xu
8 shared publications- Weiqi Sheng
Department of Pathology Fudan University Shanghai Cancer Center Shanghai China
7 shared publications - Guoxiang Cai
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
6 shared publications - Xia Meng
Department of Basic Theory of Traditional Chinese Medicine, School of Basic Medicine, Guangxi University of Chinese Medicine, Nanning City, Guangxi, China
6 shared publications
Latest Publications
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 65K, Association between samples' characteristics and signature prediction outcomes.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 65K, Association between samples' characteristics and signature prediction outcomes.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 151K, On the heat map, red colors indicate genes upregulated and green colors indicate genes downregulated. Among the 263 genes, 179 were up-regulated and 84 were down-regulated in the cancer patients, respectively. On the hierarchical clustering diagram, green bars represent controls and red bars represent CRC patients. Two hundred samples appeared to be distributed into two major separate clusters with few overlaps, revealing distinct gene expression patterns between the CRC group and the Control group.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 151K, On the heat map, red colors indicate genes upregulated and green colors indicate genes downregulated. Among the 263 genes, 179 were up-regulated and 84 were down-regulated in the cancer patients, respectively. On the hierarchical clustering diagram, green bars represent controls and red bars represent CRC patients. Two hundred samples appeared to be distributed into two major separate clusters with few overlaps, revealing distinct gene expression patterns between the CRC group and the Control group.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 70K, Signature genes enriched in Gene Ontology and KEGG pathway.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 70K, Signature genes enriched in Gene Ontology and KEGG pathway.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 58K, The table list primer sequences for 18 signature genes and 3 reference genes.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 58K, The table list primer sequences for 18 signature genes and 3 reference genes.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 65K, Association between samples' characteristics and signature prediction outcomes.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer
PDF file - 65K, Association between samples' characteristics and signature prediction outcomes.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1 - 4, Figures 1 - 4 from MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma
PDF file - 543K, Table S1. Patient information. Table S2. Primers sequences. Table S3. siRNA sequences for potential target genes Table S4. Downregulated genes in miR-202-3p-transfected LoVo cells. Fig S1: The influence of miR-202-3p T:N expression ratios levels on the overall survival of CRC patients. Fig S2: The effect of miR-202-3p on tumor formation in a nude mouse xenograft model. Fig S3: The expression levels of ARL5A mRNA in HCT-116 and LoVo cells infected with miR-202-3p or control lentiviruses were determined by qRT-PCR. Beta-actin mRNA served as an internal control. Fig S4: Immunohistochemical staining of ARL5A in the CRC and NCT samples is shown.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1 - 4, Figures 1 - 4 from MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma
PDF file - 543K, Table S1. Patient information. Table S2. Primers sequences. Table S3. siRNA sequences for potential target genes Table S4. Downregulated genes in miR-202-3p-transfected LoVo cells. Fig S1: The influence of miR-202-3p T:N expression ratios levels on the overall survival of CRC patients. Fig S2: The effect of miR-202-3p on tumor formation in a nude mouse xenograft model. Fig S3: The expression levels of ARL5A mRNA in HCT-116 and LoVo cells infected with miR-202-3p or control lentiviruses were determined by qRT-PCR. Beta-actin mRNA served as an internal control. Fig S4: Immunohistochemical staining of ARL5A in the CRC and NCT samples is shown.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1 - 4, Figures 1 - 4 from MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma
PDF file - 543K, Table S1. Patient information. Table S2. Primers sequences. Table S3. siRNA sequences for potential target genes Table S4. Downregulated genes in miR-202-3p-transfected LoVo cells. Fig S1: The influence of miR-202-3p T:N expression ratios levels on the overall survival of CRC patients. Fig S2: The effect of miR-202-3p on tumor formation in a nude mouse xenograft model. Fig S3: The expression levels of ARL5A mRNA in HCT-116 and LoVo cells infected with miR-202-3p or control lentiviruses were determined by qRT-PCR. Beta-actin mRNA served as an internal control. Fig S4: Immunohistochemical staining of ARL5A in the CRC and NCT samples is shown.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1 - 4, Figures 1 - 4 from MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma
PDF file - 543K, Table S1. Patient information. Table S2. Primers sequences. Table S3. siRNA sequences for potential target genes Table S4. Downregulated genes in miR-202-3p-transfected LoVo cells. Fig S1: The influence of miR-202-3p T:N expression ratios levels on the overall survival of CRC patients. Fig S2: The effect of miR-202-3p on tumor formation in a nude mouse xenograft model. Fig S3: The expression levels of ARL5A mRNA in HCT-116 and LoVo cells infected with miR-202-3p or control lentiviruses were determined by qRT-PCR. Beta-actin mRNA served as an internal control. Fig S4: Immunohistochemical staining of ARL5A in the CRC and NCT samples is shown.